Rilzabrutinib for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine

PHASE2CompletedINTERVENTIONAL
Enrollment

161

Participants

Timeline

Start Date

November 24, 2021

Primary Completion Date

July 19, 2023

Study Completion Date

April 23, 2024

Conditions
Chronic Spontaneous Urticaria
Interventions
DRUG

rilzabrutinib

Tablet, oral use

DRUG

placebo

Tablet, oral use

Trial Locations (128)

402

Investigational Site Number :1580003, Taichung

833

Investigational Site Number : 1580004, Kaohsiung City

Investigational Site Number :1580004, Kaohsiung City

2000

Investigational Site Number : 0320004, Rosario

Investigational Site Number : 0320005, Rosario

Investigational Site Number :0320004, Rosario

Investigational Site Number :0320005, Rosario

10002

Investigational Site Number : 1580001, Taipei

Investigational Site Number :1580001, Taipei

10117

Investigational Site Number :2760002, Berlin

12200

Investigational Site Number : 2760002, Berlin

12462

Investigational Site Number : 3000001, Athens

Investigational Site Number :3000001, Athens

14004

Investigational Site Number : 7240002, Córdoba

Investigational Site Number :7240002, Córdoba

15355

Investigational Site Number : 4100005, Ansan-si

Investigational Site Number :4100005, Ansan-si

16121

Investigational Site Number : 3000002, Athens

Investigational Site Number :3000002, Athens

20122

Investigational Site Number : 3800001, Milan

Investigational Site Number :3800001, Milan

20161

Investigational Site Number :3800004, Milan

24105

Investigational Site Number : 2760005, Kiel

Investigational Site Number :2760005, Kiel

28223

Investigational Site Number :7240007, Pozuelo de Alarcón

30059

Investigational Site Number : 1580002, Hsinchu

Investigational Site Number :1580002, Hsinchu

31008

Investigational Site Number : 7240006, Pamplona

Investigational Site Number :7240003, Pamplona

Investigational Site Number :7240006, Pamplona

40201

Investigational Site Number : 1580003, Taichung

41009

Investigational Site Number : 7240004, Seville

Investigational Site Number :7240004, Seville

49241

Investigational Site Number : 4100002, Busan

55131

Investigational Site Number : 2760004, Mainz

Investigational Site Number :2760004, Mainz

56403

Investigational Site Number : 3000003, Thessaloniki

56429

Investigational Site Number : 3000004, N. Efkarpia

Investigational Site Number :3000004, N. Efkarpia

Investigational Site Number :3000003, Thessaloniki

60126

Investigational Site Number : 3800002, Ancona

Investigational Site Number :3800002, Ancona

115522

Investigational Site Number : 6430005, Moscow

Investigational Site Number :6430005, Moscow

Investigational Site Number :6430006, Moscow

123182

Investigational Site Number : 6430002, Moscow

Investigational Site Number :6430002, Moscow

193231

Investigational Site Number :6430003, Saint Petersburg

214006

Investigational Site Number :6430004, Smolensk

355020

Investigational Site Number : 6430001, Stavropol

Investigational Site Number :6430001, Stavropol

5310644

Investigational Site Number : 1520004, Osorno

Investigational Site Number :1520004, Osorno

7640881

Investigational Site Number : 1520001, Santiago

Investigational Site Number :1520001, Santiago

7750000

Investigational Site Number :1520003, Santiago

8420383

Investigational Site Number : 1520002, Santiago

C1055AAO

Investigational Site Number : 0320006, CABA

Investigational Site Number :0320006, CABA

C1414AIF

Investigational Site Number : 0320002, CABA

Investigational Site Number :0320002, CABA

S2000JKR

Investigational Site Number : 0320003, Rosario

Investigational Site Number :0320003, Rosario

C1121ABE

Investigational Site Number : 0320001, Buenos Aires

Investigational Site Number :0320001, Buenos Aires

T2W 4X9

Investigational Site Number :1240010, Calgary

T4P 1K4

Investigational Site Number : 1240009, Red Deer

Investigational Site Number :1240009, Red Deer

M3B 3S6

Investigational Site Number : 1240005, Toronto

Investigational Site Number :1240005, Toronto

M5G 1E2

Investigational Site Number : 1240004, Toronto

Investigational Site Number :1240004, Toronto

H4A 3T2

Investigational Site Number : 1240006, Montreal

Investigational Site Number :1240006, Montreal

G8T 7A1

Investigational Site Number : 1240002, Trois-Rivières

Investigational Site Number :1240002, Trois-Rivières

G1V 4W2

Investigational Site Number : 1240003, Québec

Investigational Site Number :1240003, Québec

Unknown

Investigational Site Number :1520002, Santiago

Investigational Site Number : 3800005, Catania

Investigational Site Number :3800005, Catania

01307

Investigational Site Number : 2760001, Dresden

Investigational Site Number :2760001, Dresden

454-8509

Investigational Site Number :3920004, Nagoya

Investigational Site Number : 3920004, Nagoya

818-0083

Investigational Site Number : 3920005, Chikushino-shi

Investigational Site Number :3920005, Chikushino-shi

063-0005

Investigational Site Number : 3920002, Sapporo

Investigational Site Number :3920002, Sapporo

252-0392

Investigational Site Number : 3920001, Sagamihara-shi

Investigational Site Number :3920001, Sagamihara-shi

221-0825

Investigational Site Number : 3920007, Yokohama

Investigational Site Number :3920007, Yokohama

693-8501

Investigational Site Number : 3920006, Izumo-shi

Investigational Site Number :3920006, Izumo-shi

190-0014

Investigational Site Number : 3920003, Tachikawa-shi

Investigational Site Number :3920003, Tachikawa-shi

3015 GD

Investigational Site Number : 5280002, Rotterdam

Investigational Site Number :5280002, Rotterdam

3584 CX

Investigational Site Number : 5280001, Utrecht

Investigational Site Number :5280001, Utrecht

50-088

Investigational Site Number :6160007, Wroclaw

53-673

Investigational Site Number : 6160007, Wroclaw

80-214

Investigational Site Number : 6160001, Gdansk

Investigational Site Number :6160001, Gdansk

80-546

Investigational Site Number : 6160009, Gdansk

Investigational Site Number :6160009, Gdansk

30-438

Investigational Site Number : 6160008, Krakow

Investigational Site Number :6160008, Krakow

31-011

Investigational Site Number : 6160004, Krakow

Investigational Site Number :6160004, Krakow

31-302

Investigational Site Number :6160003, Krakow

91-211

Investigational Site Number : 6160005, Lodz

Investigational Site Number :6160005, Lodz

50-566

Investigational Site Number : 6160006, Wroclaw

Investigational Site Number :6160006, Wroclaw

602-739

Investigational Site Number :4100002, Busan

03080

Investigational Site Number :4100001, Seoul

06973

Investigational Site Number : 4100003, Seoul

Investigational Site Number :4100003, Seoul

Hyllm University Med

Investigational Site Number : 4100004, Yeongdeunpo-gu

Investigational Site Number :4100004, Yeongdeunpo-gu

08003

Investigational Site Number : 7240001, Barcelona

Investigational Site Number :7240001, Barcelona

08208

Investigational Site Number : 7240008, Barcelona / Sabadell

Investigational Site Number :7240008, Barcelona / Sabadell

03010

Investigational Site Number : 7240005, Alicante

Investigational Site Number :7240005, Alicante

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY